Generic Name |
Manufacturer |
Brand (Trade) Name |
|
|
Esomeprazole Magnesium Delayed-Release for Oral Suspension, 10 mg |
Cipla Limited |
Nexium (Esomeprazole Magnesium) Delayed-Release for Oral Suspension, 10 mg |
3/23/2020 |
For the treatment of gastroesophageal reflux disease, risk reduction of NSAID associated gastric ulcer, H. pylori eradication to reduce the risk of duodenal ulcer recurrence, and pathological hypersecretory conditions |
Esomeprazole Magnesium Delayed-Release for Oral Suspension, 20 mg, 40 mg |
Cipla Limited |
Nexium (Esomeprazole Magnesium) Delayed-Release for Oral Suspension, 20 mg, 40 mg |
3/23/2020 |
For the treatment of gastroesophageal reflux disease, risk reduction of NSAID associated gastric ulcer, H. pylori eradication to reduce the risk of duodenal ulcer recurrence, and pathological hypersecretory conditions |
Carfilzomib for Injection, 30 mg Single-Dose Vial |
Apotex Inc. |
Kyprolis (Carfilzomib) for Injection, 30 mg Single-Dose Vial |
3/20/2020 |
For the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy |
Dabigatran Etexilate Capsules, 75 mg, 150 mg |
Alkem Laboratories Limited. |
Pradaxa (Dabigatran Etexilate) 75 mg, 150 mg |
3/11/2020 |
To reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation; for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE); for the prophylaxis of DVT and PE in certain patients |
Prednisolone Sodium Phosphate Oral Solution, 30 mg/5 mL |
Pharmaceutical Associates, Inc. |
Orapred (Prednisolone Sodium Phosphate) Oral Solution, 30 mg/5 ml |
3/11/2020 |
For the control of severe or incapacitating allergic conditions: seasonal or perennial allergic rhinitis; asthma, contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions |
Melphalan for Injection, 50 mg Single-Dose
Vial |
Actavis LLC |
Evomela (Melphalan) for Injection, 50 mg Single-Dose Vial |
3/6/2020 |
For the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate |
Thiotepa for Injection USP, 15 mg/vial, 100 mg/vial Single-Dose Vials |
MSN Laboratories Private Limited |
Tepadina (Thiotepa) for Injection USP, 15 mg/vial, 100 mg/vial Single-Dose Vials |
3/4/2020 |
For the treatment of adenocarcinoma of the breast or ovary; controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities; treating superficial papillary carcinoma of the urinary bladder |
Metformin Hydrochloride Oral Solution, 500 mg/5 mL |
Saptalis Pharmaceuticals LLC |
Riomet (Metformin Hydrochloride) Oral Solution, |
3/3/2020 |
For improving glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus |
Dihydroergotamine Mesylate Nasal Spray, 4 mg/mL (1 mL Vial) |
Custopharm, Inc. |
2/28/2020 |
For the acute treatment of migraine headaches with or without aura |
|
Pyrimethamine Tablets, 25 mg |
Cerovene, Inc. |
2/26/2020 |
For the treatment of toxoplasmosis when used conjointly with a sulfonamide |
|
Albuterol Sulfate Inhalation Aerosol, 90 mcg/actuation |
Perrigo Pharmaceuticals Company |
ProAir HFA (Albuterol Sulfate Inhalation Aerosol), 90 mcg/actuation |
2/24/2020 |
For the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease; prevention of exercise-induced bronchospasm in patients 4 years of age and older |
Watson Laboratories, Inc. |
2/19/2020 |
For the treatment of ocular itching associated with allergic conjunctivitis |
||
Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, 375 mg/20 mg and 500 mg/20 mg |
Dr. Reddy's Laboratories Limited |
Vimovo (Naproxen and Esomeprazole Magnesium)Delayed-Release Tablets,375 mg/20 mg and 500 mg/20 mg |
2/18/2020 |
For the symptomatic relief of arthritis to decrease the risk of developing naproxen-associated gastric ulcers. |
Sodium Iodide I 131 Solution USP and Sodium Iodide I 131 Capsules USP,1000 mCi/mL |
International Isotopes, Inc. |
Hicon (Sodium Iodide I 131) Solution and Capsules, 1000 mCi/mL, |
2/5/2020 |
For the treatment of hyperthyroidism and selected cases of carcinoma of the thyroid |
Hydrocodone Bitartrate Extended-Release Capsules, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg |
Alvogen Malta Operations Ltd. |
Zohydro ER (Hydrocodone Bitartrate Extended-Release) Capsules, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, and 50 mg |
1/21/2020 |
For the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequat |